| Programmatic Interagency EHE |
Committee, Work group, Advisory group, or Task Force |
CDC, HRSA |
NIAID |
The Programmatic Interagency EHE (PIE) Group was formed to facilitate knowledge sharing and capacity building across EHE implementing agencies, identify opportunities for innovation and coordination, build a shared repertoire of resources and ideas, and connect with other federal colleagues working on EHE activities across the various agencies. |
| Proteomics Scientific Interest Group |
Committee, Work group, Advisory group, or Task Force |
FDA |
NCI, NHLBI, NIAID, NIDA, NIDCR |
ProtIG is an NIH Special Interest Group (SIG) that organizes seminars and workshops in relevant areas of proteomics, including talks on separation and protein identification methods, determination of post-translational modifications, protein-protein interactions, and bioinformatics and data management. A monthly seminar series is usually held at 12 pm on the Second Thursday of each month. |
| Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE) Advisory Council |
Committee, Work group, Advisory group, or Task Force |
ASPR |
NIAID, OD/IMOD |
Replaces the old PHEMCE Executive Steering Committee (ESC). Comprised of directors of each PHEMCE agency that are convened by the ASPR to provide council/advise on enterprise issues to include requirements and the SNS, etc. |
| Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE) Equity Executives Committee |
Committee, Work group, Advisory group, or Task Force |
ASPR |
NIAID |
Replaced the old PHEMCE Executive Enterprise Committee (EEC). comprised of senior executives within each PHEMCE agency that convene to coordinate MCM development across the USG. |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) |
Committee, Work group, Advisory group, or Task Force |
ASPR |
NIAID, NIAMS, NINDS, NLM, OD/IMOD |
The Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE) advances national preparedness for natural, accidental, and intentional threats by coordinating medical countermeasure-related efforts within HHS and in cooperation with PHEMCE interagency partners. NIAID has representatives on many groups within PHEMCE. |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Personal Protective Equipment (PPE) Working Group (WG) |
Committee, Work group, Advisory group, or Task Force |
ASPR, CDC, FDA |
OD/OM, OD/OM/ORS |
This WG is a consolidation of the Gowns/gloves and Respiratory Protective Device (RPD) WGs into a single PPE WG that will address a broader set of topics. The primary purpose of the PPE WG is to analyze, strategize, and provide recommendations on matters pertinent to PPE within the context of public health emergencies. The PPE WG shall aid in developing strategies to address key cross-cutting policy and acquisition issues related to the research, development, acquisition, deployment, utilization, monitoring, and evaluation of PPE in consideration of available programmatic resources at the Federal, State, local, tribal and territorial levels. |
| Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Preparedness Against Chemical Threats (PACT) Working Group |
Committee, Work group, Advisory group, or Task Force |
ASPR |
NIAID, NINDS |
The US Department of Health and Human Services (HHS) Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) leads the mission to develop and acquire medical countermeasures that will improve public health emergency preparedness as well as prevent and mitigate the adverse health consequences associated with chemical, biological, radiological and nuclear (CBRN), and naturally occurring threats.https://www.medicalcountermeasures.gov/ |
| Public Health Service Technology Transfer Policy Board |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA |
NCATS, NCI, NIAID, NIDA, OD/OER, OD/OIR, OD/OSP, OD/OTT |
The purpose of the Public Health Service (PHS) Technology Transfer Policy Board (TTPB) is to serve as the principal advisory board for establishing PHS technology transfer policies and modifying existing policies, as applicable. Membership is drawn from the National Institutes of Health (NIH) as lead agency in the PHS technology transfer program, the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). |
| Public Wastewater Surveillance Consortium |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA |
NIAID, NIBIB, NIDA, NLM |
The Public Wastewater Surveillance Consortium provides an interagency platform to enhance the use of wastewater and other environmental data for public health bio-surveillance. The group will identify key topic areas, foster discussion among stakeholders, and develop standards and best practices for analyzing and sharing environmental bio-surveillance data. |
| Quantum Barcoding for analysis of Ebola infection |
Other |
FDA |
NIAID |
Viral MIBI and Quantum barcoding: These projects are part of a Food and Drug Administration (FDA) contract with Dr. Gary Nolan's group at Stanford. The first project will develop and validate an assay for nucleic acid-based method for viral detection on the MIBI, compatible with Formalin-Fixed Paraffin-Embedded tissue, and then apply to Ebola samples. The second will use quantum barcoding to develop anti-human and anti-macaque antibody reagents, to hep develop a system that will replace multiplexing technologies such as high parameter FACS and CyTOF with a platform based on sequence tags (rather than fluorophores or mass tags) that uses decontaminated and ambient temperature-stable samples. This will be applied to BSL-3/4 samples. |